Drug Shortage Report for TEVA-COTRIDIN

Last updated on 2022-08-18 History
Report ID 115202
Drug Identification Number 02169126
Brand name TEVA-COTRIDIN
Common or Proper name COTRIDIN SYRUP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TRIPROLIDINE HYDROCHLORIDE PSEUDOEPHEDRINE HYDROCHLORIDE CODEINE PHOSPHATE
Strength(s) 2MG 30MG 10MG
Dosage form(s) SYRUP
Route of administration ORAL ORAL
Packaging size 100ml
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-13
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-08-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-08-18 French Compare
v9 2022-08-18 English Compare
v8 2021-06-30 French Compare
v7 2021-06-30 English Compare
v6 2021-01-14 French Compare
v5 2021-01-14 English Compare
v4 2020-06-18 French Compare
v3 2020-06-18 English Compare
v2 2020-05-14 French Compare
v1 2020-05-14 English Compare

Showing 1 to 10 of 10